These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9932817)

  • 1. Two-dimensional electrophoretic analysis of membranous protein from human thyroid tissues and cancer cell lines.
    Lin JD; Chan EC; Weng HF; Sheu CA
    Electrophoresis; 1998 Dec; 19(18):3213-6. PubMed ID: 9932817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of xenografts and cell lines from well-differentiated human thyroid carcinoma.
    Lin JD; Chao TC; Weng HF; Huang HS; Ho YS
    J Surg Oncol; 1996 Oct; 63(2):112-8. PubMed ID: 8888804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of cathepsin B up-regulation in neoplastic thyroid tissues by proteomic analysis.
    Srisomsap C; Subhasitanont P; Otto A; Mueller EC; Punyarit P; Wittmann-Liebold B; Svasti J
    Proteomics; 2002 Jun; 2(6):706-12. PubMed ID: 12112852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
    Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of membrane proteins from benign and malignant human thyroid tissues by two-dimensional polyacrylamide gel electrophoresis.
    Lin JD; Huang CC; Weng HF; Chen SC; Jeng LB
    J Chromatogr B Biomed Appl; 1995 May; 667(1):153-60. PubMed ID: 7663678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma.
    Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
    Jpn J Clin Oncol; 2007 Sep; 37(9):647-51. PubMed ID: 17704536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
    Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
    Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INSL-3 is expressed in human hyperplastic and neoplastic thyrocytes.
    Hombach-Klonisch S; Hoang-Vu C; Kehlen A; Hinze R; Holzhausen HJ; Weber E; Fischer B; Dralle H; Klonisch T
    Int J Oncol; 2003 May; 22(5):993-1001. PubMed ID: 12684664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
    Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
    Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome analysis identified maspin as a special feature of papillary thyroid carcinoma.
    Boltze C; Schneider-Stock R; Quednow C; Gerlach R; Mawrin C; Hinze R; Roessner A; Hoang-Vu C
    Int J Oncol; 2003 Nov; 23(5):1323-8. PubMed ID: 14532972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.
    Ciampi R; Vivaldi A; Romei C; Del Guerra A; Salvadori P; Cosci B; Pinchera A; Elisei R
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):57-62. PubMed ID: 18571834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An updated audit of fine needle aspiration cytology procedure of solitary thyroid nodule.
    Bukhari MH; Niazi S; Hanif G; Qureshi SS; Munir M; Hasan M; Naeem S
    Diagn Cytopathol; 2008 Feb; 36(2):104-12. PubMed ID: 18181183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine needle aspiration cytology of thyroid nodule: diagnostic accuracy and pitfalls.
    Mahar SA; Husain A; Islam N
    J Ayub Med Coll Abbottabad; 2006; 18(4):26-9. PubMed ID: 17591005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine needle aspiration cytology in diagnosis and management of thyroid disease.
    Bajaj Y; De M; Thompson A
    J Laryngol Otol; 2006 Jun; 120(6):467-9. PubMed ID: 16526971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid disorders. Part III: neoplastic thyroid disease.
    Little JW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):275-80. PubMed ID: 16920533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating thyroid cancer markers.
    Gupta M; Chia SY
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.